Willcox Timothy W, Mitchell Simon J
Green Lane Clinical Perfusion, Auckland City Hospital, New Zealand, and Faculty of Medicine and Health Sciences, University of Auckland, Auckland, New Zealand.
J Extra Corpor Technol. 2009 Dec;41(4):P31-7.
Cardiopulmonary bypass (CPB) may introduce microemboli into the patient's arterial circulation. These may arise from the CPB circuit. Most relevant studies have been performed in vitro; there are relatively few clinical studies. We used the Emboli Detection and Classification quantifier (EDAC) (Luna Innovations, Roanoke, VA) in a prospective clinical audit of emboli in a contemporary CPB circuit. Following ethics approval, standard clinical CPB circuits in patients undergoing CPB were instrumented with three EDAC system probes placed on the venous line, outlet of the hard-shell venous reservoir (HSVR), and distal to the arterial line filter. This was synchronized with the perfusion data management system and emboli number and volume were recorded at 30-second intervals. Recorded observations and combined data from both the EDAC and data management system were analyzed. We report data from the first 12 patients (24.5 hours of CPB) of a larger series currently being performed. The mean total emboli count per minute was significantly greater downstream of the HSVR than in the venous line and significantly less downstream of the arterial line filter than either of the above. The total count downstream of both the HSVR and the arterial line filter was greater when the vent pump was on vs. off. Despite the significant increase in emboli count downstream of the reservoir during vent operation there was a significant reduction in the total volume of emboli in this position compared with the venous line. This was further reduced by the arterial line filter. Nevertheless, the total embolic volume was greater downstream of the HSVR and the arterial filter with the vent on vs. off. The two overwhelming sources of emboli emanating from our CPB circuit were the use of the left ventricular vent and air entrained from the venous line. Such audit enables refinement of CPB management and potential component redesign which may make CPB safer and improve patient outcome.
体外循环(CPB)可能会将微栓子引入患者的动脉循环。这些微栓子可能源于体外循环回路。大多数相关研究是在体外进行的;临床研究相对较少。我们在对当代体外循环回路中的栓子进行的前瞻性临床审计中使用了栓子检测与分类定量仪(EDAC)(Luna Innovations公司,弗吉尼亚州罗阿诺克)。在获得伦理批准后,对接受体外循环的患者的标准临床体外循环回路进行了仪器安装,在静脉管路、硬壳静脉储血器(HSVR)出口以及动脉管路过滤器远端放置了三个EDAC系统探头。这与灌注数据管理系统同步,并每隔30秒记录栓子数量和体积。对记录的观察结果以及来自EDAC和数据管理系统的综合数据进行了分析。我们报告了目前正在进行的一个更大系列研究中前12例患者(24.5小时体外循环)的数据。每分钟的平均总栓子计数在HSVR下游显著高于静脉管路,而在动脉管路过滤器下游显著低于上述两者中的任何一个。当排气泵开启时,HSVR和动脉管路过滤器下游的总计数均高于关闭时。尽管排气操作期间储血器下游的栓子计数显著增加,但与静脉管路相比,该位置的栓子总体积显著减少。动脉管路过滤器进一步降低了栓子总体积。然而,排气泵开启时HSVR和动脉过滤器下游的总栓子体积仍大于关闭时。我们体外循环回路中栓子的两个主要来源是左心室排气的使用和从静脉管路夹带的空气。这样的审计有助于优化体外循环管理以及对潜在组件进行重新设计,这可能会使体外循环更安全并改善患者预后。